Canadian Manufacturing

Canada continues to invest in domestic vaccine production

by CM staff   

Financing Manufacturing Public Sector biomanufacturing capacity. Canada domestic vaccine production therapeutics vaccines

Investment in Jubilant HollisterStier will strengthen Canada's biomanufacturing capacity for vaccine and therapeutics production.

KIRKLAND —Since March 2020, over $1.8 billion has been invested across 34 projects to rebuild Canada’s vaccines, therapeutics and biomanufacturing capacity.

Pablo Rodriguez, Minister of Canadian Heritage and Quebec Lieutenant, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a contribution of $23.8 million to support Jubilant HollisterStier’s $108.3 million project through the Strategic Innovation Fund.

This project will increase Jubilant HollisterStier’s annual fill and finish capacity once completed. This investment supports the growth of Canada’s life sciences ecosystem, while driving innovation. With this contribution, Jubilant HollisterStier will create and maintain 311 jobs in Quebec.

“Ambitious companies like Jubilant HollisterStier are positioning Quebec as a world leader in the biomanufacturing and life sciences sector,” said Pablo Rodriguez, Minister of Canadian Heritage and Quebec Lieutenant. “With projects like today’s, we are supporting the growth of a strategic industry and creating and maintaining good jobs, all while generating wealth here at home.”



Stories continue below